// App-Quantinova.ai

P466 : Real world effectiveness of vedolizumab over one year in inflammatory bowel disease: a meta-analysis

Researchers

Presenter

  • S. Schreiber

Principal Investigators

  • A. Dignass

  • L. Peyrin-Biroulet

  • G. Hather

  • D. Demuth

  • J.M. Khalid

  • E.V. Loftus

Medical Centers

  • University Hospital Schleswig-Holstein, Institute of Clinical Molecular Biology, Kiel, Germany

  • Agaplesion Markus Hospital, Department of Medicine I, Frankfurt, Germany

  • Nancy University Hospital, Dpt. Gastroenterology, Vandoeuvre, France

  • Takeda Development Center, Stats Innovation, Massachusetts, United Kingdom

  • Takeda Development Centre Europe Ltd., Evidence and Value Generation, London, UK

  • Takeda Development Centre Europe Ltd., Evidence and Value Generation, London, UK

  • Mayo Clinic College of Medicine, Gastroenterology and Hepatology, Minnesota, United Kingdom

Locations

  • Germany

  • France

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Infectious Diseases (ID)

  • Genetic Disorder

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Entyvio

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved